Depomed (DEPO) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total other income (expense): -20.19M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Total other income (expense): -20.19M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q1 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $104.8 million versus the consensus estimate of $107.1 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Morgan Stanley Starts ARCHION Corp (543A:JP) at Equalweight
- Everus Construction Group acquires Epsilon Industries for $295M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
